Turning Promise Into Progress
Dana-Farber Science Uncovers Differences Between Early-Onset and Average-Age-Onset Colorectal Cancer
Immunotherapy Combo Extends Survival for Patients with Aggressive Small Cell Lung Cancer, Based on Trial Results Presented by Dana-Farber at ESMO Congress 2026
Perioperative Apalutamide in High-Risk Localized or Locally Advanced Prostate Cancer Substudy Supports Reduced Risk of Metastasis and Death
Dana-Farber Breaks Ground on Lavine Bekenstein Cancer Hospital
Dana-Farber Scientists Reveal How Follicular Lymphoma Transitions to More Aggressive Disease
Novel Antibody-Drug Conjugate Demonstrates Durable Responses in Patients With Platinum-Resistant Ovarian Cancer
Novel Treatment Combination Improves Progression-Free Survival in Most Common Form of Metastatic Breast Cancer
Dana-Farber Researchers Find Blood Test Could Guide Future Treatment in Ewing Sarcoma
Expand Treatment Options for Patients with Peritoneal Metastases With an Early Cytoreduction Surgical Evaluation
Rare Inherited EGFR Mutation Linked to Dramatically Increased Lung Cancer Risk
Making Invisible Cancers Visible: Study Suggests a New Route to Turn ‘Cold’ Tumors ‘Hot’
Dana-Farber’s Edward Chouchani, PhD, selected as a 2026 Blavatnik National Award finalist
The Storied Career Of Clinical Physicist Dr. Charlie Ma: From Philadelphia To Cancer Centers Worldwide
Building a System of Focused Care for Lobular Breast Cancer
Showing 1 - 15 of 1098 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...74 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account